BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30911906)

  • 1. Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules.
    Wang Y; Yu M; Yan B; Martin P; Robertson B
    Drugs R D; 2019 Jun; 19(2):167-175. PubMed ID: 30911906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Safety, and Tolerability of SHP465 Mixed Amphetamine Salts After Administration of Multiple Daily Doses in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity Disorder.
    Ilic K; Kugler AR; Yan B; McNamara N
    CNS Drugs; 2022 Jan; 36(1):71-81. PubMed ID: 34826114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration.
    Tulloch SJ; Zhang Y; McLean A; Wolf KN
    Pharmacotherapy; 2002 Nov; 22(11):1405-15. PubMed ID: 12432966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.
    Ermer JC; Shojaei A; Pennick M; Anderson CS; Silverberg A; Youcha SH
    Curr Med Res Opin; 2007 May; 23(5):1067-75. PubMed ID: 17519073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (Qelbree
    Wang Z; Kosheleff AR; Adeojo LW; Odebo O; Liranso T; Schwabe S; Nasser A
    Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):69-79. PubMed ID: 34652564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of AR19, an Immediate-Release Amphetamine Sulfate Formulation Designed to Deter Manipulation for Administration Via Nonoral Routes: Bioequivalence to Reference Racemic Amphetamine Sulfate, Dose Proportionality, and Food Effect.
    Caras S; Sharpe T
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):69-80. PubMed ID: 31809216
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
    Stark JG; Engelking D; McMahen R; Sikes C
    Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate bioavailability in adults when an extended-release multiparticulate formulation is administered sprinkled on food or as an intact capsule.
    Pentikis HS; Simmons RD; Benedict MF; Hatch SJ
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):443-9. PubMed ID: 11931601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
    Wigal T; Brams M; Frick G; Yan B; Madhoo M
    Postgrad Med; 2018 Jun; 130(5):481-493. PubMed ID: 29809075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD.
    Wigal S; Lopez F; Frick G; Yan B; Robertson B; Madhoo M
    Postgrad Med; 2019 Apr; 131(3):212-224. PubMed ID: 30681017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink.
    Ermer J; Corcoran M; Lasseter K; Martin PT
    Ther Drug Monit; 2016 Dec; 38(6):769-776. PubMed ID: 27661399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce.
    Lee L; Kepple J; Wang Y; Freestone S; Bakhtiar R; Wang Y; Hossain M
    Biopharm Drug Dispos; 2003 Sep; 24(6):233-43. PubMed ID: 12973820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults.
    Liu T; Gobburu JVS; Po MD; McLean A; DeSousa NJ; Sallee FR; Incledon B
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):181-191. PubMed ID: 30810347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
    Sikes CR; McMahen RL; Stark JG; Engelking D
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):29-35. PubMed ID: 28933918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
    Marraffino A; Sikes CR; Laage T; Volosov A; Hart A; Engelking D
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):15-20. PubMed ID: 31295008
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment.
    Wigal T; Childress A; Frick G; Yan B; Wigal S; Madhoo M
    Postgrad Med; 2018 Jan; 130(1):111-121. PubMed ID: 29087231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults.
    Katzman MA; Mattingly G; Klassen LJ; Cataldo MJ; Donnelly GAE
    J Clin Psychopharmacol; 2020; 40(6):579-587. PubMed ID: 33009228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR; Fitzpatrick A; Stewart J; Runyan JD
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.